Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala)

Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala)

Background: Thiazolidinediones (TZDs) improves insulin sensitivity by activating the peroxisome proliferator-activated receptor γ (PPAR-g). We aimed to study any association between variation in bone biochemical markers and single nucleotide polymorphism (SNP) in PPAR-γ (Pro12Ala) and investigate if...

Full description

Bibliographic Details
Main Authors: Fatemeh Namvaran, Parvaneh Rahimi-Moghaddam, Negar Azarpira, Mohammad Hossein Dabbaghmanesh, Marzieh Bakhshayeshkaram, Mohamad Mahdi Namvaran
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Bone biological markers
diabetic patient
insulin resistance
Iranian population
osteoporosis
polymorphisms PPAR-γ
pioglitazone
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=4;spage=277;epage=282;aulast=Namvaran

Internet

http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=4;spage=277;epage=282;aulast=Namvaran

Similar Items